Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (8)

Search Parameters:
Keywords = HDV evolution

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
18 pages, 7157 KiB  
Article
Proportional-Switch Adjustment Process-Based Day-by-Day Evolution Model for Mixed Traffic Flow in an Autonomous Driving Environment
by Yihao Huang, Han Zhang and Aiwu Kuang
World Electr. Veh. J. 2025, 16(1), 53; https://doi.org/10.3390/wevj16010053 - 20 Jan 2025
Viewed by 887
Abstract
Given the rapid development of technologies such as new energy vehicles, autonomous driving, and vehicle-to-everything (V2X) communication, a mixed traffic flow comprising connected and autonomous vehicles (CAVs) and human-driven vehicles (HDVs) is anticipated to emerge. This necessitates the development of a daily dynamic [...] Read more.
Given the rapid development of technologies such as new energy vehicles, autonomous driving, and vehicle-to-everything (V2X) communication, a mixed traffic flow comprising connected and autonomous vehicles (CAVs) and human-driven vehicles (HDVs) is anticipated to emerge. This necessitates the development of a daily dynamic evolution model for mixed traffic flow to address the dynamic traffic management needs of urban environments characterized by mixed traffic. The daily dynamic evolution model can capture the temporal evolution of traffic flow in road networks, with a focus on the daily path choice behavior of travelers and the evolving traffic flow in the network. First, based on the travel characteristics of CAVs and HDVs, the user group in a connected autonomous driving environment is classified into three categories, each adhering to the system optimal (SO) criterion, the user equilibrium (UE) criterion, or the stochastic user equilibrium (SUE) criterion. Next, the pure HDV traffic capacity BPR (Bureau of Public Roads) function is adapted into a heterogeneous traffic flow travel time function to compute the travel time cost for mixed traffic flow. Based on the energy consumption calculation formula for HDVs, the impact of CAVs is fully considered to establish the travel energy consumption cost for both CAVs and HDVs. The total individual travel cost for CAVs and HDVs encompasses both travel time cost and energy consumption cost. Furthermore, a daily dynamic evolution model for mixed traffic flow in a connected autonomous driving environment is developed using the proportional-switch adjustment process (PAP) model. The fundamental properties of the model are validated. Finally, numerical simulations on an N-dimensional (N-D) network confirm the validity and effectiveness of the daily evolution model for mixed traffic flow. A sensitivity analysis of traveler responses in the daily evolution model reveals that, as the sensitivity of CAVs to impedance changes increases, the fluctuations in mixed traffic flow during the early stages of evolution become more pronounced, and the time required to reach a mixed-equilibrium state decreases. Therefore, the PAP-based daily dynamic evolution model for mixed traffic flow effectively captures the evolution process of CAV and HDV mixed traffic flow and supports urban traffic management in a connected autonomous driving environment. Full article
(This article belongs to the Special Issue Vehicle Safe Motion in Mixed Vehicle Technologies Environment)
Show Figures

Figure 1

13 pages, 5282 KiB  
Article
Analysis of Replication, Cell Division-Mediated Spread, and HBV Envelope Protein-Dependent Pseudotyping of Three Mammalian Delta-like Agents
by Gnimah Eva Gnouamozi, Zhenfeng Zhang, Vibhu Prasad, Chris Lauber, Stefan Seitz and Stephan Urban
Viruses 2024, 16(6), 859; https://doi.org/10.3390/v16060859 - 28 May 2024
Cited by 1 | Viewed by 2238
Abstract
The human hepatitis delta virus (HDV) is a satellite RNA virus that depends on hepatitis B virus (HBV) surface proteins (HBsAg) to assemble into infectious virions targeting the same organ (liver) as HBV. Until recently, the evolutionary origin of HDV remained largely unknown. [...] Read more.
The human hepatitis delta virus (HDV) is a satellite RNA virus that depends on hepatitis B virus (HBV) surface proteins (HBsAg) to assemble into infectious virions targeting the same organ (liver) as HBV. Until recently, the evolutionary origin of HDV remained largely unknown. The application of bioinformatics on whole sequence databases lead to discoveries of HDV-like agents (DLA) and shed light on HDV’s evolution, expanding our understanding of HDV biology. DLA were identified in heterogeneous groups of vertebrates and invertebrates, highlighting that the evolution of HDV, represented by eight distinct genotypes, is broader and more complex than previously foreseen. In this study, we focused on the characterization of three mammalian DLA discovered in woodchuck (Marmota monax), white-tailed deer (Odocoileus virginianus), and lesser dog-like bat (Peropteryx macrotis) in terms of replication, cell-type permissiveness, and spreading pathways. We generated replication-competent constructs expressing 1.1-fold over-length antigenomic RNA of each DLA. Replication was initiated by transfecting the cDNAs into human (HuH7, HeLa, HEK293T, A549) and non-human (Vero E6, CHO, PaKi, LMH) cell lines. Upon transfection and replication establishment, none of the DLA expressed a large delta antigen. A cell division-mediated viral amplification assay demonstrated the capability of non-human DLA to replicate and propagate in hepatic and non-hepatic tissues, without the requirement of envelope proteins from a helper virus. Remarkably L-HDAg but not S-HDAg from HDV can artificially mediate envelopment of WoDV and DeDV ribonucleoproteins (RNPs) by HBsAg to form infectious particles, as demonstrated by co-transfection of HuH7 cells with the respective DLA expression constructs and a plasmid encoding HBV envelope proteins. These chimeric viruses are sensitive to HDV entry inhibitors and allow synchronized infections for comparative replication studies. Our results provide a more detailed understanding of the molecular biology, evolution, and virus–host interaction of this unique group of animal viroid-like agents in relation to HDV. Full article
(This article belongs to the Special Issue Life Cycle of Hepatitis D Virus (HDV) and HDV-Like Agents)
Show Figures

Figure 1

19 pages, 2653 KiB  
Article
Global Distribution and Natural Recombination of Hepatitis D Virus: Implication of Kyrgyzstan Emerging HDVs in the Clinical Outcomes
by Amina Nawal Bahoussi, Pei-Hua Wang, Yan-Yan Guo, Nighat Rabbani, Changxin Wu and Li Xing
Viruses 2022, 14(7), 1467; https://doi.org/10.3390/v14071467 - 2 Jul 2022
Cited by 7 | Viewed by 2579
Abstract
Discrepancies in human hepatitis delta virus (HDV) genotypes impact the virus’ biological behavior, clinical manifestation, and treatment response. Herein, this report aims to explore the role of recombination in the worldwide genotypic distribution and genetic diversity of HDV. Three-hundred-forty-eight human HDV full-length genomic [...] Read more.
Discrepancies in human hepatitis delta virus (HDV) genotypes impact the virus’ biological behavior, clinical manifestation, and treatment response. Herein, this report aims to explore the role of recombination in the worldwide genotypic distribution and genetic diversity of HDV. Three-hundred-forty-eight human HDV full-length genomic sequences of ~1678 nt in length, isolated in twenty-eight countries worldwide between 1986 and 2018, were analysed. Similarity analysis and recombination mapping were performed, and forty-eight recombination events were identified, twenty-nine of which were isolated from Kyrgyzstan and determined to be involved in the diversity and extension of HDV sub-genotypes. HDV recombination occurred only between the genetically close genotypes (genotype 5 and genotype 2) or mainly within genotype 1, suggesting the complex replicative molecular mechanisms of HDV-RNA. The global distribution and classification of HDV genotypes have been updated, indicating that HDV recombination is one of the driving forces behind the biodiversity and the evolution of human HDV genomes. The outcome analysis suggests that the expansion of HDV sub-genotypes and the complex recombination networks might be related to the genomic character of Kyrgyzstan circulating strains and extensive mobility within countries and across borders. These findings will be of great importance in formulating more effective public health HDV surveillance strategies and guiding future molecular and epidemiological research to achieve better clinical outcomes. Full article
(This article belongs to the Special Issue Viral Infections in Developing Countries, Volume II)
Show Figures

Figure 1

18 pages, 384 KiB  
Review
Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?
by Giorgio Maria Saracco, Alfredo Marzano and Mario Rizzetto
Biomedicines 2022, 10(3), 534; https://doi.org/10.3390/biomedicines10030534 - 24 Feb 2022
Cited by 4 | Viewed by 3564
Abstract
Chronic viral hepatitis determines significant morbidity and mortality globally and is caused by three main etiological actors (Hepatitis B Virus, Hepatitis C Virus, and Hepatitis D Virus) with different replicative cycles and biological behaviors. Thus, therapies change according to the different characteristics of [...] Read more.
Chronic viral hepatitis determines significant morbidity and mortality globally and is caused by three main etiological actors (Hepatitis B Virus, Hepatitis C Virus, and Hepatitis D Virus) with different replicative cycles and biological behaviors. Thus, therapies change according to the different characteristics of the viruses. In chronic hepatitis B, long term suppressive treatments with nucleoside/nucleotide analogues have had a dramatic impact on the evolution of liver disease and liver-related complications. However, a conclusive clearance of the virus is difficult to obtain; new strategies that are able to eradicate the infection are currently objects of research. The therapy for Hepatitis D Virus infection is challenging due to the unique virology of the virus, which uses the synthetic machinery of the infected hepatocyte for its own replication and cannot be targeted by conventional antivirals that are active against virus-coded proteins. Recently introduced antivirals, such as bulevertide and lonafarnib, display definite but only partial efficacy in reducing serum HDV-RNA. However, in combination with pegylated interferon, they provide a synergistic therapeutic effect and appear to represent the current best therapy for HDV-positive patients. With the advent of Direct Acting Antiviral Agents (DAAs), a dramatic breakthrough has occurred in the therapeutic scenario of chronic hepatitis C. Cure of HCV infection is achieved in more than 95% of treated patients, irrespective of their baseline liver fibrosis status. Potentially, the goal of global HCV elimination by 2030 as endorsed by the World Health Organization can be obtained if more global subsidised supplies of DAAs are provided. Full article
13 pages, 1488 KiB  
Article
Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and Variability
by Beatriz Pacin-Ruiz, María Francesca Cortese, David Tabernero, Sara Sopena, Josep Gregori, Selene García-García, Rosario Casillas, Adrián Najarro, Unai Aldama, Adriana Palom, Ariadna Rando-Segura, Anna Galán, Marta Vila, Mar Riveiro-Barciela, Josep Quer, Gloria González-Aseguinolaza, María Buti and Francisco Rodríguez-Frías
Viruses 2022, 14(2), 215; https://doi.org/10.3390/v14020215 - 22 Jan 2022
Cited by 7 | Viewed by 4215
Abstract
The hepatitis delta virus (HDV) genome has an autocatalytic region called the ribozyme, which is essential for viral replication. The aim of this study was to use next-generation sequencing (NGS) to analyze the ribozyme quasispecies (QS) in order to study its evolution and [...] Read more.
The hepatitis delta virus (HDV) genome has an autocatalytic region called the ribozyme, which is essential for viral replication. The aim of this study was to use next-generation sequencing (NGS) to analyze the ribozyme quasispecies (QS) in order to study its evolution and identify highly conserved regions potentially suitable for a gene-silencing strategy. HDV RNA was extracted from 2 longitudinal samples of chronic HDV patients and the ribozyme (nucleotide, nt 688–771) was analyzed using NGS. QS conservation, variability and genetic distance were analyzed. Mutations were identified by aligning sequences with their specific genotype consensus. The main relevant mutations were tested in vitro. The ribozyme was conserved overall, with a hyper-conserved region between nt 715–745. No difference in QS was observed over time. The most variable region was between nt 739–769. Thirteen mutations were observed, with three showing a higher frequency: T23C, T69C and C64 deletion. This last strongly reduced HDV replication by more than 1 log in vitro. HDV Ribozyme QS was generally highly conserved and was maintained during follow-up. The most conserved portion may be a valuable target for a gene-silencing strategy. The presence of the C64 deletion may strongly impair viral replication, as it is a potential mechanism of viral persistence. Full article
(This article belongs to the Special Issue Hepatitis Delta Virus)
Show Figures

Figure 1

15 pages, 1848 KiB  
Article
Constraint of Base Pairing on HDV Genome Evolution
by Saki Nagata, Ryoji Kiyohara and Hiroyuki Toh
Viruses 2021, 13(12), 2350; https://doi.org/10.3390/v13122350 - 23 Nov 2021
Cited by 2 | Viewed by 2322
Abstract
The hepatitis delta virus is a single-stranded circular RNA virus, which is characterized by high self-complementarity. About 70% of the genome sequences can form base-pairs with internal nucleotides. There are many studies on the evolution of the hepatitis delta virus. However, the secondary [...] Read more.
The hepatitis delta virus is a single-stranded circular RNA virus, which is characterized by high self-complementarity. About 70% of the genome sequences can form base-pairs with internal nucleotides. There are many studies on the evolution of the hepatitis delta virus. However, the secondary structure has not been taken into account in these studies. In this study, we developed a method to examine the effect of base pairing as a constraint on the nucleotide substitutions during the evolution of the hepatitis delta virus. The method revealed that the base pairing can reduce the evolutionary rate in the non-coding region of the virus. In addition, it is suggested that the non-coding nucleotides without base pairing may be under some constraint, and that the intensity of the constraint is weaker than that by the base pairing but stronger than that on the synonymous site. Full article
(This article belongs to the Special Issue RNA Viruses: Structure, Adaptation, and Evolution)
Show Figures

Figure 1

15 pages, 1078 KiB  
Review
HDV-Like Viruses
by Jimena Pérez-Vargas, Rémi Pereira de Oliveira, Stéphanie Jacquet, Dominique Pontier, François-Loïc Cosset and Natalia Freitas
Viruses 2021, 13(7), 1207; https://doi.org/10.3390/v13071207 - 23 Jun 2021
Cited by 28 | Viewed by 4795
Abstract
Hepatitis delta virus (HDV) is a defective human virus that lacks the ability to produce its own envelope proteins and is thus dependent on the presence of a helper virus, which provides its surface proteins to produce infectious particles. Hepatitis B virus (HBV) [...] Read more.
Hepatitis delta virus (HDV) is a defective human virus that lacks the ability to produce its own envelope proteins and is thus dependent on the presence of a helper virus, which provides its surface proteins to produce infectious particles. Hepatitis B virus (HBV) was so far thought to be the only helper virus described to be associated with HDV. However, recent studies showed that divergent HDV-like viruses could be detected in fishes, birds, amphibians, and invertebrates, without evidence of any HBV-like agent supporting infection. Another recent study demonstrated that HDV can be transmitted and propagated in experimental infections ex vivo and in vivo by different enveloped viruses unrelated to HBV, including hepatitis C virus (HCV) and flaviviruses such as Dengue and West Nile virus. All this new evidence, in addition to the identification of novel virus species within a large range of hosts in absence of HBV, suggests that deltaviruses may take advantage of a large spectrum of helper viruses and raises questions about HDV origins and evolution. Full article
(This article belongs to the Special Issue Hepatitis Delta Virus)
Show Figures

Figure 1

17 pages, 2309 KiB  
Article
HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets
by Luna Colagrossi, Romina Salpini, Rossana Scutari, Luca Carioti, Arianna Battisti, Lorenzo Piermatteo, Ada Bertoli, Lavinia Fabeni, Carmine Minichini, Pascale Trimoulet, Hervé Fleury, Elena Nebuloso, Maria De Cristofaro, Giuseppina Cappiello, Alberto Spanò, Vincenzo Malagnino, Terenzio Mari, Angelo Barlattani, Nerio Iapadre, Miriam Lichtner, Claudio Mastroianni, Ilaria Lenci, Caterina Pasquazzi, Giuseppe Maria De Sanctis, Alfonso Galeota Lanza, Maria Stanzione, Gianfranca Stornaiuolo, Massimo Marignani, Loredana Sarmati, Massimo Andreoni, Mario Angelico, Francesca Ceccherini-Silberstein, Carlo-Federico Perno, Nicola Coppola and Valentina Svicheradd Show full author list remove Hide full author list
Viruses 2018, 10(7), 363; https://doi.org/10.3390/v10070363 - 9 Jul 2018
Cited by 8 | Viewed by 4935
Abstract
Chronic HBV + HDV infection is associated with greater risk of liver fibrosis, earlier hepatic decompensation, and liver cirrhosis hepatocellular carcinoma compared to HBV mono-infection. However, to-date no direct anti-HDV drugs are available in clinical practice. Here, we identified conserved and variable regions [...] Read more.
Chronic HBV + HDV infection is associated with greater risk of liver fibrosis, earlier hepatic decompensation, and liver cirrhosis hepatocellular carcinoma compared to HBV mono-infection. However, to-date no direct anti-HDV drugs are available in clinical practice. Here, we identified conserved and variable regions in HBsAg and HDAg domains in HBV + HDV infection, a critical finding for the design of innovative therapeutic agents. The extent of amino-acid variability was measured by Shannon-Entropy (Sn) in HBsAg genotype-d sequences from 31 HBV + HDV infected and 62 HBV mono-infected patients (comparable for demographics and virological-parameters), and in 47 HDAg genotype-1 sequences. Positions with Sn = 0 were defined as conserved. The percentage of conserved HBsAg-positions was significantly higher in HBV + HDV infection than HBV mono-infection (p = 0.001). Results were confirmed after stratification for HBeAg-status and patients’ age. A Sn = 0 at specific positions in the C-terminus HBsAg were correlated with higher HDV-RNA, suggesting that conservation of these positions can preserve HDV-fitness. Conversely, HDAg was characterized by a lower percentage of conserved-residues than HBsAg (p < 0.001), indicating higher functional plasticity. Furthermore, specific HDAg-mutations were significantly correlated with higher HDV-RNA, suggesting a role in conferring HDV replicative-advantage. Among HDAg-domains, only the virus-assembly signal exhibited a high genetic conservation (75% of conserved-residues). In conclusion, HDV can constrain HBsAg genetic evolution to preserve its fitness. The identification of conserved regions in HDAg poses the basis for designing innovative targets against HDV-infection. Full article
(This article belongs to the Section Animal Viruses)
Show Figures

Figure 1

Back to TopTop